Tore Lind Selected Research

Esomeprazole (Nexium)

8/2016	A 14-day regimen of esomeprazole 20 mg/day for frequent heartburn: durability of effects, symptomatic rebound, and treatment satisfaction.
5/2016	Gastroesophageal Acid Reflux Control 5 Years After Antireflux Surgery, Compared With Long-term Esomeprazole Therapy.
1/2015	Long-term effect on symptoms and quality of life of maintenance therapy with esomeprazole 20 mg daily: a post hoc analysis of the LOTUS trial.
7/2014	Esomeprazole treatment of frequent heartburn: two randomized, double-blind, placebo-controlled trials.
5/2011	Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial.
2/2011	Safety and tolerability of high-dose intravenous esomeprazole for prevention of peptic ulcer rebleeding.
6/2010	Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study.
5/2010	Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study.
5/2010	Long-term outcome of microscopic esophagitis in chronic GERD patients treated with esomeprazole or laparoscopic antireflux surgery in the LOTUS trial.
1/2010	Cost effectiveness of high-dose intravenous esomeprazole for peptic ulcer bleeding.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tore Lind Research Topics

Disease

15	Gastroesophageal Reflux (GERD) 01/2017 - 10/2004
5	Hemorrhage 02/2017 - 04/2009
5	Peptic Ulcer (Peptic Ulcers) 02/2017 - 04/2009
5	Heartburn (Pyrosis) 08/2016 - 01/2008
2	Flatulence 05/2011 - 12/2009
2	Deglutition Disorders (Dysphagia) 05/2011 - 12/2009
1	Ulcer 01/2017
1	Infections 01/2015
1	Neoplasms (Cancer) 10/2012
1	Adenocarcinoma 10/2012
1	Barrett Esophagus (Barrett's Esophagus) 10/2012
1	Hiatal Hernia 10/2012
1	Duodenal Ulcer (Curling's Ulcer) 02/2011
1	Injection Site Reaction 02/2011
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 02/2011
1	Atrophy 01/2011
1	Atrophic Gastritis 01/2011
1	Asthma (Bronchial Asthma) 05/2010
1	Esophagitis 05/2010
1	Peptic Esophagitis (Reflux Esophagitis) 12/2009

Drug/Important Bio-Agent (IBA)

13	Esomeprazole (Nexium)FDA Link 08/2016 - 10/2004
8	Proton Pump InhibitorsIBA 02/2017 - 01/2008
8	AcidsIBA 01/2017 - 10/2004
2	Omeprazole (Prilosec)FDA LinkGeneric 12/2009 - 10/2004
2	Pantoprazole (Protonix)FDA LinkGeneric 01/2008 - 10/2004
1	FIIaIBA 01/2017
1	AntacidsIBA 08/2016
1	DiamondIBA 12/2012
1	Pharmaceutical PreparationsIBA 05/2011
1	Pepsinogen A (Pepsinogen)IBA 01/2011
1	AntralIBA 01/2011
1	PepsinogensIBA 01/2011
1	Biomarkers (Surrogate Marker)IBA 01/2011
1	gastrin 17 (G 17)IBA 01/2011
1	ORALIT (ORS)IBA 01/2008
1	Rabeprazole (Aciphex)FDA Link 10/2004
1	Lansoprazole (Prevacid)FDA LinkGeneric 10/2004

Therapy/Procedure

13	Therapeutics 01/2017 - 01/2008
1	Endoscopic Hemostasis 01/2017
1	Aftercare (After-Treatment) 08/2016
1	Intravenous Infusions 02/2011
1	Fundoplication 05/2010
1	Blood Transfusion (Blood Transfusions) 04/2009
1	Drug Substitution 01/2008